Study of pattern of dyslipidemia and its correlation with cardiovascular risk factors in patients with proven coronary artery disease

Indian Journal of Endocrinology and Metabolism

Volumn 18, Issue 1, 2014, Pages 48-55

  Mahalle, Namita ^a   Garg, M ^b   Naik, Sadanand ^a   Kulkarni, Mohan ^c  

^a DEENANATH MANGESHKAR HOSPITAL   (India)

^b CHSC   (India)

^c UNIVERSITY OF PUNE   (India)

Author keywords

Coronary artery disease; diabetes mellitus; dyslipidemia hypertension; inflammatory markers

Indexed keywords

EID: 84995495876     PISSN: 22308210     EISSN: 22309500     Source Type: Journal    
DOI: 10.4103/2230-8210.126532     Document Type: Article

References (50)

1. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007;125:217-30.
2. Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 2007;297:286-94.
3. Gaziano TA, Reddy KS, Paccaud F, Horton S, Chaturvedi V. Cardiovascular disease. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al., editors. Disease Control Priorities in Developing Countries. 2 nd ed. New York: Oxford University Press; 2006. p. 645-62.
4. Radha V, Mohan V. Genetic predisposition to type 2 diabetes among Asian Indians. Indian J Med Res 2007;125:259-74.
5. Yajnik CS. Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries. J Nutr 2004;134:205-10.
6. McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 1993;87:152-61.
7. Enas EA, Mehta J. Malignant coronary artery disease in young Asian Indians: Thoughts on pathogenesis, prevention, and therapy. Coronary Artery Disease in Asian Indians Study. Clin Cardiol 1995;18:131-5.
8. Gupta M, Brister S. Is South Asian ethnicity an independent cardiovascular risk factor? Can J Cardiol 2006;22:193-7.
9. Genest JG Jr. Dyslipidemia and coronary artery disease. Can J Cardiol 2000;16 Suppl A:3A-4.
10. Karthikeyan G, Teo KK, Islam S, McQueen MJ, Pais P, Wang X, et al. Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: An analysis from the INTERHEART Study. J Am Coll Cardiol 2009;53:244-53.
11. Labreuche J, Touboul PJ, Amarenco P. Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: A systematic review of the epidemiological studies. Atherosclerosis 2009;203:331-45.
12. Amarenco P, Labreuche J, Touboul PJ. High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: A systematic review. Atherosclerosis 2008;196:489-96.
13. McBride PE. Triglycerides and risk for coronary heart disease. J Am Med Assoc 2007;298:336-8.
14. Rizos E, Mikhailidis DP. Are high density lipoprotein and triglyceride levels relevant in stroke prevention? Cardiovasc Res 2001;52:199-207.
15. Fruchart JC, Sacks F, Hermans MP, Assmann G, Brown WV, Ceska R, et al. The residual risk reduction initiative: A call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol 2008;102:1K-34.
16. McKeigue PM, Miller GJ, Marmot MG. Coronary heart disease in south Asians overseas: A review. J Clin Epidemiol 1989;42:597-609.
17. Bhalodkar NC, Blum S, Rana T, Bhalodkar A, Kitchappa R, Kim KS, et al. Comparison of levels of large and small high-density lipoprotein cholesterol in Asian Indian men compared with Caucasian men in the Framingham offspring study. Am J Cardiol 2004;94:1561-3.
18. Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, et al. American association of clinical endocrinologists' guidelines for management of Dyslipidemia and prevention of atherosclerosis. Endocr Pract 2012;18 Suppl 1:1-78.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
20. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10.
21. Mahalle N, Kulkarni MV, Garg MK, Naik SS. Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease. J Cardiol 2013;61:289-94.
22. Gupta R, Vasisht S, Bahl VK, Wasir HS. Correlation of lipoprotein (a) to angiographically defined coronary artery disease in Indians. Int J Cardiol 1996;57:265-70.
23. Mohan V, Deepa R, Rani SS, Premalatha G, Chennai Urban Population Study (CUPS No. 5). Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: The Chennai urban population study (CUPS No. 5). J Am Coll Cardiol 2001;38:682-7.
24. Arca M, Montali A, Valiante S, Campagna F, Pigna G, Paoletti V, et al. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease. Am J Cardiol 2007;100:1511-6.
25. Sharma SB, Garg S, Veerwal A, Dwivedi S. hs-CRP and oxidative stress in young CAD patients: A pilot study. Indian J Clin Biochem 2008;23:334-6.
26. Sirimarco G, Deplanque D, Lavallée PC, Labreuche J, Meseguer E, Cabrejo L, et al. Atherogenic dyslipidemia in patients with transient ischemic attack. Stroke 2011;42:2131-7.
27. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple risk factor intervention trial research group. Arch Intern Med 1992;152:56-64.
28. Levy D, Kannel WB. Cardiovascular risks: New insights from Framingham. Am Heart J 1988;116:266-72.
29. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004;109:42-6.
30. Micah FB, Nkum BC. Lipid disorders in hospital attendants in Kumasi, Ghana. Ghana Med J 2012;46:14-21.
31. World Health Organization. Obesity: Preventing and managing the global epidemic. WHO Technical Report Series: No 894. Geneva: WHO; 2000.
32. Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India 2009;57:163-70.
33. Wyszynski DF, Waterworth DM, Barter PJ, Cohen J, Kesäniemi YA, Mahley RW, et al. Relation between atherogenic dyslipidemia and the adult treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol 2005;95:194-8.
34. Hermans MP, Ahn SA, Rousseau MF. The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females. Lipids Health Dis 2012;11:132.
35. Grundy SM. Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance. Clin Cornerstone 2006;8 Suppl 1:S21-7.
36. Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003;52:812-7.
37. Amanullah S, Jarari A, Govindan M, Basha MI, Khatheeja S. Association of HS-CRP with diabetic and non-diabetic individuals. Jordan J Biol Sci 2010;3:7-12.
38. Bhagwat R, Gupte A, Yadav KS. Diagnostic utility of HS-CRP in coronary heart disease. Int J Mol Biol 2012:3:36-9.
39. Rao VS, Kadarinarasimhiah NB, John S, Hebbagodi S, Shanker J, Kakkar VV. Usefulness of C-reactive protein as a marker for prediction of future coronary events in the asian Indian population: Indian atherosclerosis research study. Int J Vasc Med 2010;389235.
40. Akalin A, Alatas O, Colak O. Relation of plasma homocysteine levels to atherosclerotic vascular disease and inflammation markers in type 2 diabetic patients. Eur J Endocrinol 2008;158:47-52.
41. Gillum RF. Distribution of total serum homocysteine and its association with parental history and cardiovascular risk factors at ages 12-16 years: The Third National Health and Nutrition Examination Survey. Ann Epidemiol 2004;14:229-33.
42. Huemer M, Vonblon K, Födinger M, Krumpholz R, Hubmann M, Ulmer H, et al. Total homocysteine, folate, and cobalamin, and their relation to genetic polymorphisms, lifestyle and body mass index in healthy children and adolescents. Pediatr Res 2006;60:764-9.
43. Shai I, Stampfer MJ, Ma J, Manson JE, Hankinson SE, Cannuscio C, et al. Homocysteine as a risk factor for coronary heart diseases and its association with inflammatory biomarkers, lipids and dietary factors. Atherosclerosis 2004;177:375-81.
44. Yadav AS, Bhagwat VR, Rathod IM. Relationship of plasma homocysteine with lipid profile parameters in ischemic heart disease. Indian J Clin Biochem 2006;21:106-10.
45. Obeid R, Herrmann W. Homocysteine and lipids: S-adenosyl methionine as a key intermediate. FEBS Lett 2009;583:1215-25.
46. Khalil A, Huffman MD, Prabhakaran D, Osmond C, Fall CH, Tandon N, et al. Predictors of carotid intima-media thickness and carotid plaque in young Indian adults: The New Delhi birth cohort. Int J Cardiol 2013;167:1322-8.
47. Radha V, Mohan V, Vidya R, Ashok AK, Deepa R, Mathias RA. Association of lipoprotein lipase Hind III and Ser 447 Ter polymorphisms with dyslipidemia in Asian Indians. Am J Cardiol 2006;97:1337-42.
48. Liao D, Yang X, Wang H. Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease. Clin Chem Lab Med 2007;45:1652-9.
49. Yajnik CS, Joglekar CV, Lubree HG, Rege SS, Naik SS, Bhat DS, et al. Adiposity, inflammation and hyperglycaemia in rural and urban Indian men: Coronary Risk of Insulin Sensitivity in Indian Subjects Study. Diabetologia 2008;51:39-46.
50. Han CY, Chiba T, Campbell JS, Fausto N, Chaisson M, Orasanu G, et al. Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes. Arterioscler Thromb Vasc Biol 2006;26:1806-13.